SCHEMBL20127437

SCHEMBL20127437

c1ccc2c(-c3c4ccccc4c(-c4cccc5ccc6ccccc6c45)c4ccccc34)c3oc4ccccc4c3cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALOX5 P09917 2/20 0.38
AHR P35869 5/20 0.36
CES1 P23141 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HIF1A Q16665 1/20 0.35
CYP1B1 Q16678 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ANPEP P15144 1/20 0.34
ERBB2 P04626 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127643 0.92 TDP1 (0.40) SOS1TDP1L3MBTL1ALOX5AHR
SCHEMBL10122563 0.89 ALOX5 (0.41) SOS1ALOX5AHRCES1MEN1
SCHEMBL20127439 0.88 SOS1 (0.46) SOS1TDP1L3MBTL1ALOX5AHR
SCHEMBL20127448 0.87 L3MBTL1 (0.38) SOS1TDP1L3MBTL1ALOX5AHR
SCHEMBL20127404 0.86 ALOX5 (0.43) TDP1L3MBTL1ALOX5AHRMEN1
SCHEMBL20127457 0.86 ALOX5 (0.48) SOS1ALOX5AHRCES1MAPT
SCHEMBL12768098 0.85 ALOX5 (0.46) TDP1L3MBTL1ALOX5AHRMEN1
SCHEMBL10122689 0.84 AHR (0.47) TDP1L3MBTL1ALOX5AHRMEN1
SCHEMBL22881818 0.84 ALDH1A1 (0.43) SOS1L3MBTL1ALOX5AHRCES1
SCHEMBL20127671 0.84 L3MBTL1 (0.41) SOS1TDP1L3MBTL1ALOX5AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 SOS1 960/4885TDP1 3427/4885L3MBTL1 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.